Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1959 1
1962 1
1963 2
1968 1
1979 1
1980 1
1987 1
1988 1
1989 1
1990 4
1991 1
1992 2
1993 3
1995 2
1996 1
1997 3
1998 1
1999 5
2000 5
2002 3
2003 4
2004 5
2005 3
2006 5
2007 12
2008 11
2009 9
2010 20
2011 24
2012 20
2013 24
2014 22
2015 23
2016 27
2017 19
2018 23
2019 19
2020 22
2021 26
2022 27
2023 26
2024 8

Text availability

Article attribute

Article type

Publication date

Search Results

367 results

Results by year

Filters applied: . Clear all
Page 1
Carboplatin and paclitaxel plus avelumab compared with carboplatin and paclitaxel in advanced or recurrent endometrial cancer (MITO END-3): a multicentre, open-label, randomised, controlled, phase 2 trial.
Pignata S, Scambia G, Schettino C, Arenare L, Pisano C, Lombardi D, De Giorgi U, Andreetta C, Cinieri S, De Angelis C, Priolo D, Casanova C, Rosati M, Greco F, Zafarana E, Schiavetto I, Mammoliti S, Cecere SC, Salutari V, Scalone S, Farolfi A, Di Napoli M, Lorusso D, Gargiulo P, Califano D, Russo D, Spina A, De Cecio R, Chiodini P, Perrone F; MITO investigators. Pignata S, et al. Lancet Oncol. 2023 Mar;24(3):286-296. doi: 10.1016/S1470-2045(23)00016-5. Epub 2023 Feb 14. Lancet Oncol. 2023. PMID: 37052965 Clinical Trial.
Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab.
Hagström E, Steg PG, Szarek M, Bhatt DL, Bittner VA, Danchin N, Diaz R, Goodman SG, Harrington RA, Jukema JW, Liberopoulos E, Marx N, McGinniss J, Manvelian G, Pordy R, Scemama M, White HD, Zeiher AM, Schwartz GG; ODYSSEY OUTCOMES Investigators. Hagström E, et al. Circulation. 2022 Aug 30;146(9):657-672. doi: 10.1161/CIRCULATIONAHA.121.057807. Epub 2022 Jun 30. Circulation. 2022. PMID: 35770629 Free PMC article. Clinical Trial.
Reducing Branded Prescription Drug Prices: A Review of Policy Options.
Alexander GC, Ballreich J, Socal MP, Karmarkar T, Trujillo A, Greene J, Sharfstein J, Anderson G. Alexander GC, et al. Among authors: trujillo a. Pharmacotherapy. 2017 Nov;37(11):1469-1478. doi: 10.1002/phar.2013. Epub 2017 Oct 17. Pharmacotherapy. 2017. PMID: 28805961 Review.
Does plant diversity benefit agroecosystems? A synthetic review.
Letourneau DK, Armbrecht I, Rivera BS, Lerma JM, Carmona EJ, Daza MC, Escobar S, Galindo V, Gutiérrez C, López SD, Mejía JL, Rangel AM, Rangel JH, Rivera L, Saavedra CA, Torres AM, Trujillo AR. Letourneau DK, et al. Among authors: trujillo ar. Ecol Appl. 2011 Jan;21(1):9-21. doi: 10.1890/09-2026.1. Ecol Appl. 2011. PMID: 21516884 Review.
Waiting for HAPO.
Trujillo AL, Jovanovic L. Trujillo AL, et al. Diabetes Metab Res Rev. 2008 May-Jun;24 Suppl 2:S1-2. doi: 10.1002/dmrr.875. Diabetes Metab Res Rev. 2008. PMID: 18429331
Short-term changes in klotho and FGF23 in heart failure with reduced ejection fraction-a substudy of the DAPA-VO2 study.
Mora-Fernández C, Pérez A, Mollar A, Palau P, Amiguet M, de la Espriella R, Sanchis J, Górriz JL, Soler MJ, Navarro-González JF, Núñez J; DAPA-VO2 Investigators; DAPA-VO Investigators. Mora-Fernández C, et al. Front Cardiovasc Med. 2023 Aug 25;10:1242108. doi: 10.3389/fcvm.2023.1242108. eCollection 2023. Front Cardiovasc Med. 2023. PMID: 37745119 Free PMC article.
Checklist of Orchidaceae from Caquetá, Colombia.
Arias T, Chaux-Varela J, Camero MDP, Calderon-Álvarez RA, Trujillo AC, Correa-Munera MA, Zuluaga A, Perdomo O, Pérez-Escobar OA, Trujillo-Trujillo E, Valencia-D J. Arias T, et al. Among authors: trujillo ac. PhytoKeys. 2023 Jul 6;229:21-46. doi: 10.3897/phytokeys.229.102737. eCollection 2023. PhytoKeys. 2023. PMID: 37457384 Free PMC article.
Short-term effects of dapagliflozin on maximal functional capacity in heart failure with reduced ejection fraction (DAPA-VO2 ): a randomized clinical trial.
Palau P, Amiguet M, Domínguez E, Sastre C, Mollar A, Seller J, Garcia Pinilla JM, Larumbe A, Valle A, Gómez Doblas JJ, de la Espriella R, Miñana G, Mezcua AR, Santas E, Bodí V, Sanchis J, Pascual-Figal D, Górriz JL, Baýes-Genís A, Núñez J; DAPA-VO2 Investigators (see Appendix). Palau P, et al. Eur J Heart Fail. 2022 Oct;24(10):1816-1826. doi: 10.1002/ejhf.2560. Epub 2022 Jun 6. Eur J Heart Fail. 2022. PMID: 35604416 Free article. Clinical Trial.
367 results